admin, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

Optimi Health Announces Receipt of Purported Termination Notice

Small Pharma Reports Fiscal First Quarter 2024 Highlights

Navigating Psychedelics: Vital Tools for Risk Reduction and Integration – Denver

Atman Psychedelic Retreat & Vital Training: Jamaica 2

Atman Psychedelic Retreat & Vital Training: Jamaica 1

Kiyumí Psilocybin Retreat & Vital Training: Netherlands

Prasada Transpersonal Breathwork Retreat: Portugal

PT426 – Making the Impossible Possible: Flow Hacking and Peak Performance...

A Call for Clarity in Psychedelic Discourse

First clinical study results of psilocybin treatment in anorexia nervosa published...

1...545556...218 Page 55 of 218

EDITOR PICKS

‘No Prejudice, No Hype’: Florence Butlen-Ducuing on Europe’s Psychedelic Renaissance

August 2025 Psychedelic Patent Update

Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin